Anderson WF - Search Results

1

Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.

Mullooly M, Murphy J, Gierach GL, Walsh PM, Deady S, Barron TI, Sherman ME, Rosenberg PS, Anderson WF. Mullooly M, et al. Among authors: anderson wf. Eur J Cancer. 2017 Nov;86:326-333. doi: 10.1016/j.ejca.2017.08.031. Epub 2017 Oct 23. Eur J Cancer. 2017. PMID: 29073583 Free PMC article.

2

Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.

Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA. Anderson WF, et al. J Clin Oncol. 2001 Jan 1;19(1):18-27. doi: 10.1200/JCO.2001.19.1.18. J Clin Oncol. 2001. PMID: 11134191

3

Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups.

Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW. Chu KC, et al. Among authors: anderson wf. Cancer. 2001 Jul 1;92(1):37-45. doi: 10.1002/1097-0142(20010701)92:1<37::aid-cncr1289>3.0.co;2-f. Cancer. 2001. PMID: 11443607

4

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.

Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Anderson WF, et al. Breast Cancer Res Treat. 2002 Nov;76(1):27-36. doi: 10.1023/a:1020299707510. Breast Cancer Res Treat. 2002. PMID: 12408373

5

Is male breast cancer similar or different than female breast cancer?

Anderson WF, Althuis MD, Brinton LA, Devesa SS. Anderson WF, et al. Breast Cancer Res Treat. 2004 Jan;83(1):77-86. doi: 10.1023/B:BREA.0000010701.08825.2d. Breast Cancer Res Treat. 2004. PMID: 14997057

6

Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.

Anderson WF, Chu KC, Chang S, Sherman ME. Anderson WF, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1128-35. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247123

7

Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications.

Anderson WF, Chu KC, Devesa SS. Anderson WF, et al. Breast Cancer Res Treat. 2004 Nov;88(2):149-59. doi: 10.1007/s10549-004-1483-9. Breast Cancer Res Treat. 2004. PMID: 15564798

8

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Hance KW, et al. Among authors: anderson wf. J Natl Cancer Inst. 2005 Jul 6;97(13):966-75. doi: 10.1093/jnci/dji172. J Natl Cancer Inst. 2005. PMID: 15998949 Free PMC article.

9

In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute.

Anderson WF, Devesa SS. Anderson WF, et al. Cancer. 2005 Oct 15;104(8):1733-41. doi: 10.1002/cncr.21353. Cancer. 2005. PMID: 16138363 Free article.

10

Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.

Anderson WF, Chen BE, Jatoi I, Rosenberg PS. Anderson WF, et al. Breast Cancer Res Treat. 2006 Nov;100(1):121-6. doi: 10.1007/s10549-006-9231-y. Epub 2006 May 10. Breast Cancer Res Treat. 2006. PMID: 16685588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

753 results

Search Page

Filters